Table 2 Responses to questions on recommended treatment and reported use of diagnostics by 29 health workers based in 21 health facilities in Nairobi
From: The clinical burden of malaria in Nairobi: a historical review and contemporary audit
1st line treatment for children below 5 kg with uncomplicated malaria | N = 29 |
|---|---|
   AL | 11 (37.9%) |
   Quinine | 15 (51.7%) |
   Amodiaquine | 2 (6.9%) |
   Don't know | 1 (3.4%) |
1 st line treatment for children > 5 kg and adults with uncomplicated malaria | Â |
   AL | 27 (93.1%) |
   SP | 2(6.9%) |
2 nd line treatment for children below 5 kg and adults with uncomplicated malaria | Â |
   AL | 4 (13.8%) |
   Quinine | 23 (79.3%) |
   DuoCotexin | 1 (3.4%) |
   Don't know | 2 (6.9%) |
2 nd line treatment for children below 5 kg and adults with uncomplicated malaria | Â |
   AL | 3 (10.3%) |
   SP | 1 (3.4%) |
   Quinine | (44.8%) |
   DuoCotexin | 2 (6.9%) |
   DHA-PPQ (dihydroartemisinin-piperoquine | 8 (27.6%) |
   Lapdap (chloroproguanil-dapsone) | 1 (3.4%) |
   Don't know | 1 (3.4%) |
Responses to questions on diagnostics - proportion agreeing with statements | Â |
All febrile patients in Nairobi should be tested for malaria | 14 (48.3%) |
Only febrile patients who recently travelled outside of Nairobi should be tested for malaria | 13 (44.8%) |
Most febrile patients in Nairobi with negative RDT should be still treated for malaria | 4 (13.8%) |
Most febrile patients in Nairobi with negative Blood Slide should be still treated for malaria | 5 (17.2%) |